Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications
Purpose: The C-X-C chemokine receptor 4 (CXCR4) is highly expressed in many subtypes of cancers, notably in several kidney-based malignancies. We synthesized, labeled, and assessed a series of radiotracers based on a previous high contrast PET imaging radiopharmaceutical [<sup>68</sup>Ga]Ga-BL02, wi...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
MDPI AG
2022-07-01
|
| Sraith: | Pharmaceutics |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/1999-4923/14/7/1502 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|